Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Will Eylea retain majority market share over its biosimilars by May 2025?  | Binary | 5 | 7 months ago | ||
Will Regeneron's stock price increase due to the launch of Eylea biosimilars by the end of 2024? | Binary | 5 | 7 months ago | ||
Financial impact on Regeneron after the launch of Eylea biosimilars by Q2 2025 | Categorical | 5 | 7 months ago | ||
Medical community's reception to Eylea biosimilars by 2025 | Categorical | 5 | 7 months ago | ||
Will Biocon and Biogen's biosimilars be launched in the US market by the end of 2024? | Binary | 4 | 7 months ago | ||
Market share competition between Biocon and Biogen's Eylea biosimilars by 2025 | Categorical | 4 | 7 months ago |